InvestorsHub Logo
Followers 105
Posts 16345
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Tuesday, 10/10/2023 7:09:27 AM

Tuesday, October 10, 2023 7:09:27 AM

Post# of 159
BioXcel Therapeutics Reports Positive Overall Survival Results from Single-Arm, Open-Label Phase 2 Trial of BXCL701 in Patients with Small Cell Neuroendocrine Prostate Cancer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BTAI News